We describe the infrastructure and functionality for a centralized preclinical and clinical data repository and analytic platform to support importing heterogeneous multi-modal data, automatically and manually linking data across modalities and sites, and searching content. We have developed and applied innovative image and electrophysiology processing methods to identify candidate biomarkers from MRI, EEG, and multi-modal data. Based on heterogeneous biomarkers, we present novel analytic tools designed to study epileptogenesis in animal model and human with the goal of tracking the probability of developing epilepsy over time.
Big data sharing and analysis to advance research in post-traumatic epilepsy We describe the infrastructure and functionality for a centralized preclinical and clinical data repository and analytic platform to support importing heterogeneous multi-modal data, automatically and manually linking data across modalities and sites, and searching content. We have developed and applied innovative image and electrophysiology processing methods to identify candidate biomarkers from MRI, EEG, and multi-modal data. Based on heterogeneous biomarkers, we present novel analytic tools designed to study epileptogenesis in animal model and human with the goal of tracking the probability of developing epilepsy over time.
Introduction
The goal of the Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) is to identify relevant biomarkers of epileptogenesis after traumatic brain injury (TBI) and perform rigorous preclinical trials that permit the future design and performance of economically feasible full-scale clinical trials of antiepileptogenic therapies. A fundamental challenge in discovering these biomarkers of epileptogenesis is that this process is multifactorial and crosses multiple modalities. Rather than considering one type of data, we have been collecting and analyzing multi-modal data, including neuroimaging, electrophysiology, and molecular/serological/tissue. Furthermore, to facilitate analysis and collaboration among scientists from various centers around the world, we have created the informatics infrastructure needed for a large dataset of this size. We have also developed innovative analytic tools that are shared with the broader epilepsy research community, including any other interested researchers outside of the epilepsy research community who might find these data useful for their research, so that others may use our tools in addition to their own tools to advance research in this field in general, in addition to identifying biomarkers of epileptogenesis after TBI.
Investigators must have access to a large number of high quality, well-curated data points and study subjects in order for biomarker signals to be detectable above the noise inherent in complex phenomena, such as epileptogenesis, TBI, and conditions of data collection.
Additionally, data generating and collecting sites are spread worldwide among different laboratories, clinical sites, heterogeneous data types, and formats, and across multi-center preclinical trials. Before the data can even be analyzed, a central platform is needed to standardize these data and provide tools for searching, viewing, annotating, and analyzing them. By centralizing an enduring data archive, biobank, and analytic tools, researchers may identify and validate biomarkers of epileptogenesis in studies using various types of data. Beyond creating a centralized data repository, we have pioneered innovative standardization/co-registration references, fully supported by novel image and electrophysiology processing methods to extract candidate biomarkers from the diverse data. Not only does a well-curated and standardized multi-modal dataset facilitate the development of models of epileptogenesis, but it also ensures that such models are statistically significant and can be validated.
EEG and MRI databases
There have been other efforts to create centralized data archives, but it has proven to be especially challenging for human neurophysiological data for many reasons, such as large file sizes, varying formats, privacy constraints, and funding. Two examples of centralized EEG databases that have been developed include Epilepsiae (Dourado et al., 2009; Ihle et al., 2012; Klatt et al., 2012; Schulze-Bonhage et al., 2010) , a European Union-funded project, and IEEG.ORG, an NINDS-
